Dino Mehic: BDUC and Its Overlap With Inherited and Rare Bleeding Disorders
Dino Mehic, Physician Scientist at Medizinische Universität Wien, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Haemophilia, adding:
”Honored to have spoken at the World Federation of Hemophilia Congress 2026 in Kuala Lumpur on Bleeding Disorder of Unknown Cause (BDUC) and its overlap with inherited and rare bleeding disorders.
The congress was also a great opportunity to interact with physicians treating bleeding disorders and with patient representatives from around the world, highlighting the importance of collaboration between clinicians, researchers, and patients to improve diagnosis and care.
Very pleased that, together with my co-authors Alessandro Casini, Robert Klamroth, Saskia Schols, Bauke Haisma we recently published our State-of-the-Art review in Haemophilia:
‘Rare Bleeding Disorders and Bleeding Disorder of Unknown Cause: Current Understanding and Recent Developments.”’
Title: Rare Bleeding Disorders and Bleeding Disorder of Unknown Cause: Current Understanding and Recent Developments
Authors: Alessandro Casini, Robert Klamroth, Bauke Haisma, Dino Mehic, Saskia E. M. Schols
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 24, 2026, 09:18The Lasting Immunological Footprint of VITT – JTH
-
Jun 24, 2026, 09:09Umberto Pensato: Dedicated Funding Pathways for Stroke Research in Italy
-
Jun 24, 2026, 09:00Danny Gaskin: BBTS 2026 and the Evolving Role of Transfusion in Maternity Care
-
Jun 24, 2026, 07:46Wolfgang Miesbach: WFH’s First AAV Gene Therapy Chapter Marks a New Era in Hemophilia Care
-
Jun 24, 2026, 06:42Deepthi Krishna: World Blood Donor Day 2026 Celebrations at Rela Hospital
-
Jun 24, 2026, 03:36Ana Pedrero Gil: A New Approach to Post-Tonsillectomy Hemorrhage
-
Jun 24, 2026, 02:59Melissa Hollo: Making Early Anemia Detection the Standard of Care
-
Jun 24, 2026, 02:51Bruno Pougault: The Thin Line Between Bleeding and Clotting
-
Jun 23, 2026, 23:30Shunsuke Iwano: PMDA Introduces Greater Flexibility for Pediatric Factor VIII and IX Development in Japan